These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9928574)

  • 21. Quality-of-life-adjusted evaluation of adjuvant therapies for operable breast cancer. The International Breast Cancer Study Group.
    Gelber RD; Goldhirsch A; Cavalli F
    Ann Intern Med; 1991 Apr; 114(8):621-8. PubMed ID: 2003707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adjuvant chemotherapy in early breast cancer.
    Ejlertsen B
    Dan Med J; 2016 May; 63(5):. PubMed ID: 27127018
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Using the 21-gene assay to guide adjuvant chemotherapy decision-making in early-stage breast cancer: a cost-effectiveness evaluation in the German setting.
    Blohmer JU; Rezai M; Kümmel S; Kühn T; Warm M; Friedrichs K; Benkow A; Valentine WJ; Eiermann W
    J Med Econ; 2013; 16(1):30-40. PubMed ID: 22966753
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Personalized adjuvant therapies: lessons from the past: the opening address by the St. Gallen 2013 award recipient.
    Goldhirsch A
    Breast; 2013 Aug; 22 Suppl 2():S3-7. PubMed ID: 24074788
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retreating recurrent breast cancer with the same CMF-containing regimen used as adjuvant therapy. The International Breast Cancer Study Group.
    Castiglione-Gertsch M; Tattersall M; Hacking A; Goldhirsch A; Gudgeon A; Gelber RD; Lindtner J; Coates A; Collins J; Isley M; Senn HJ; Rudenstam CM
    Eur J Cancer; 1997 Dec; 33(14):2321-5. PubMed ID: 9616275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Third line chemotherapy in patients with metastatic breast cancer: an evaluation of quality of life and cost.
    McLachlan SA; Pintilie M; Tannock IF
    Breast Cancer Res Treat; 1999 Apr; 54(3):213-23. PubMed ID: 10445420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Age of menopause among women who remain premenopausal following treatment for early breast cancer: long-term results from International Breast Cancer Study Group Trials V and VI.
    Partridge A; Gelber S; Gelber RD; Castiglione-Gertsch M; Goldhirsch A; Winer E
    Eur J Cancer; 2007 Jul; 43(11):1646-53. PubMed ID: 17512721
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized clinical trial of adjuvant chemotherapy for radically resected locoregional relapse of breast cancer: IBCSG 27-02, BIG 1-02, and NSABP B-37.
    Wapnir IL; Aebi S; Geyer CE; Zahrieh D; Gelber RD; Anderson SJ; Robidoux A; Bernhard J; Maibach R; Castiglione-Gertsch M; Coates AS; Piccart MJ; Clemons MJ; Costantino JP; Wolmark N; ; ;
    Clin Breast Cancer; 2008 Jun; 8(3):287-92. PubMed ID: 18650162
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of International Breast Cancer Study Group Trial 10-93.
    ; Rudenstam CM; Zahrieh D; Forbes JF; Crivellari D; Holmberg SB; Rey P; Dent D; Campbell I; Bernhard J; Price KN; Castiglione-Gertsch M; Goldhirsch A; Gelber RD; Coates AS
    J Clin Oncol; 2006 Jan; 24(3):337-44. PubMed ID: 16344321
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemotherapy versus ovarian ablation as adjuvant therapy for breast cancer: impact on health-related quality of life in a randomized trial.
    Groenvold M; Fayers PM; Petersen MA; Mouridsen HT
    Breast Cancer Res Treat; 2006 Aug; 98(3):275-84. PubMed ID: 16541325
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tamoxifen: a review of pharmacoeconomic and quality-of-life considerations for its use as adjuvant therapy in women with breast cancer.
    Bryson HM; Plosker GL
    Pharmacoeconomics; 1993 Jul; 4(1):40-66. PubMed ID: 10146967
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: the International Breast Cancer Study Group Trial VII.
    Crivellari D; Bonetti M; Castiglione-Gertsch M; Gelber RD; Rudenstam CM; Thürlimann B; Price KN; Coates AS; Hürny C; Bernhard J; Lindtner J; Collins J; Senn HJ; Cavalli F; Forbes J; Gudgeon A; Simoncini E; Cortes-Funes H; Veronesi A; Fey M; Goldhirsch A
    J Clin Oncol; 2000 Apr; 18(7):1412-22. PubMed ID: 10735888
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adjuvant chemotherapy followed by goserelin versus either modality alone for premenopausal lymph node-negative breast cancer: a randomized trial.
    ; Castiglione-Gertsch M; O'Neill A; Price KN; Goldhirsch A; Coates AS; Colleoni M; Nasi ML; Bonetti M; Gelber RD
    J Natl Cancer Inst; 2003 Dec; 95(24):1833-46. PubMed ID: 14679153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quality-of-life changes over time in breast cancer patients undergoing breast-conserving surgery: a prospective study in Greece.
    Eskitzis P; Zafrakas M; Papanicolaou A; Panagopoulou E; Gkoutzioulis M; Sympilidis G; Tarlatzis BC
    Arch Gynecol Obstet; 2016 Sep; 294(3):639-45. PubMed ID: 27086287
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quality of life in elderly patients with localized breast cancer treated with radiotherapy. A prospective study.
    Arraras JI; Manterola A; Asin G; Illarramendi JJ; Cruz Sde L; Ibañez B; Delfrade J; Salgado E; Zarandona U; Cambra K; Vera R; Dominguez MA
    Breast; 2016 Apr; 26():46-53. PubMed ID: 27017241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adjuvant therapy for breast cancer.
    NIH Consens Statement; 2000 Nov 1-3; 17(4):1-35. PubMed ID: 11512506
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Responsiveness of a single-item indicator versus a multi-item scale: assessment of emotional well-being in an international adjuvant breast cancer trial.
    Hürny C; Bernhard J; Coates A; Peterson HF; Castiglione-Gertsch M; Gelber RD; Rudenstam CM; Collins J; Lindtner J; Goldhirsch A; Senn HJ
    Med Care; 1996 Mar; 34(3):234-48. PubMed ID: 8628043
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current and future status of adjuvant therapy for breast cancer.
    Coleman RE
    Cancer; 2003 Feb; 97(3 Suppl):880-6. PubMed ID: 12548590
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quality of life evaluation in oncological clinical trials - the EORTC model. The EORTC Quality of Life Study Group.
    de Haes J; Curran D; Young T; Bottomley A; Flechtner H; Aaronson N; Blazeby J; Bjordal K; Brandberg Y; Greimel E; Maher J; Sprangers M; Cull A
    Eur J Cancer; 2000 May; 36(7):821-5. PubMed ID: 10785585
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The best available adjuvant treatments are within the framework of clinical trials. The International Breast Cancer Study Group.
    Goldhirsch A; Gelber RD; Castiglione M; Price KN; Rudenstam CM; Lindtner J; Collins J; Senn HJ; Cavalli F; Galligioni E
    Isr J Med Sci; 1995; 31(2-3):144-54. PubMed ID: 7744584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.